| Product NDC: | 51097-001 |
| Proprietary Name: | Adasuve |
| Non Proprietary Name: | loxapine |
| Active Ingredient(s): | 10 mg/1 & nbsp; loxapine |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | AEROSOL, POWDER |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51097-001 |
| Labeler Name: | Alexza Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022549 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121221 |
| Package NDC: | 51097-001-02 |
| Package Description: | 5 INHALER in 1 CARTON (51097-001-02) > 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) |
| NDC Code | 51097-001-02 |
| Proprietary Name | Adasuve |
| Package Description | 5 INHALER in 1 CARTON (51097-001-02) > 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) |
| Product NDC | 51097-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | loxapine |
| Dosage Form Name | AEROSOL, POWDER |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20121221 |
| Marketing Category Name | NDA |
| Labeler Name | Alexza Pharmaceuticals, Inc. |
| Substance Name | LOXAPINE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |